Cisplatin Induces Resistance by Triggering Differentiation of Testicular Embryonal Carcinoma Cells

Abstract excerpt

Although testicular germ cell tumors are generally quite responsive to treatment with cisplatin, a small fraction of them acquire resistance during therapy. Even when cisplatin treatment is successful the patient is often left with a residual teratoma at the site of the primary tumor suggesting that cisplatin may trigger differentiation in some tumors. Using the human embryonal carcinoma cell line NTera2/D1, we...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chemotherapy-induced organ toxicity mitigation
• Share to Renal and related cancers
• Share to Testicular diseases and treatments